Primary acquired chronic pure red cell aplasia refractory to standard treatments: remission with rituximab

Detalles Bibliográficos
Autores principales: Tendas, Andrea, Niscola, Pasquale, Scaramucci, Laura, Cupelli, Luca, Perrotti, Alessio Pio, de Fabritiis, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931933/
https://www.ncbi.nlm.nih.gov/pubmed/27382560
http://dx.doi.org/10.5045/br.2016.51.2.137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931933/
https://www.ncbi.nlm.nih.gov/pubmed/27382560
http://dx.doi.org/10.5045/br.2016.51.2.137

Ejemplares similares